ReP USP - Resultado da busca

Artigo de periodico
N,N,N-trimethylchitosan-poly (n-butylcyanoacrylate) core-shell nanoparticles as a potential oral delivery system for acyclovir (2020)
Tavares, Guilherme Diniz; Gonçalves, José Eduardo; Monteiro, Lis Marie ; Löbenberg, Raimar ; Storpirtis, Silvia ; Bou-Chacra, Nadia Araci ; Consiglieri, Vladi Olga
Source: Colloids and Surfaces B. Unidade: FCF
Subjects: NANOPARTÍCULAS, QUITOSANA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAVARES, Guilherme Diniz et al. N,N,N-trimethylchitosan-poly (n-butylcyanoacrylate) core-shell nanoparticles as a potential oral delivery system for acyclovir. Colloids and Surfaces B, v. 196, p. 1-9 art. 111336, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfb.2020.111336. Acesso em: 16 out. 2024.
APA
Tavares, G. D., Gonçalves, J. E., Monteiro, L. M., Löbenberg, R., Storpirtis, S., Bou-Chacra, N. A., & Consiglieri, V. O. (2020). N,N,N-trimethylchitosan-poly (n-butylcyanoacrylate) core-shell nanoparticles as a potential oral delivery system for acyclovir. Colloids and Surfaces B, 196, 1-9 art. 111336. doi:10.1016/j.colsurfb.2020.111336
NLM
Tavares GD, Gonçalves JE, Monteiro LM, Löbenberg R, Storpirtis S, Bou-Chacra NA, Consiglieri VO. N,N,N-trimethylchitosan-poly (n-butylcyanoacrylate) core-shell nanoparticles as a potential oral delivery system for acyclovir [Internet]. Colloids and Surfaces B. 2020 ; 196 1-9 art. 111336.[citado 2024 out. 16 ] Available from: https://doi.org/10.1016/j.colsurfb.2020.111336
Vancouver
Tavares GD, Gonçalves JE, Monteiro LM, Löbenberg R, Storpirtis S, Bou-Chacra NA, Consiglieri VO. N,N,N-trimethylchitosan-poly (n-butylcyanoacrylate) core-shell nanoparticles as a potential oral delivery system for acyclovir [Internet]. Colloids and Surfaces B. 2020 ; 196 1-9 art. 111336.[citado 2024 out. 16 ] Available from: https://doi.org/10.1016/j.colsurfb.2020.111336
Artigo de periodico
A new medium-throughput screening design approach for the development of hydroxymethylnitrofurazone (NFOH) nanostructured lipid carrier for treating leishmaniasis (2020)
Souza, Aline de ; Yukuyama, Megumi Nishitani ; Barbosa, Eduardo José ; Monteiro, Lis Marie ; Faloppa, Ana Cristina Breithaupt; Calixto, Leandro Augusto; Araujo, Gabriel Lima Barros de ; Fotaki, Nikoletta; Löbenberg, Raimar ; Bou-Chacra, Nadia Araci
Source: Colloids and Surfaces B: Biointerfaces. Unidade: FCF
Subjects: NANOPARTÍCULAS, LIPÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Aline de et al. A new medium-throughput screening design approach for the development of hydroxymethylnitrofurazone (NFOH) nanostructured lipid carrier for treating leishmaniasis. Colloids and Surfaces B: Biointerfaces, v. 193, p. 1-8 art. 111097, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfb.2020.111097. Acesso em: 16 out. 2024.
APA
Souza, A. de, Yukuyama, M. N., Barbosa, E. J., Monteiro, L. M., Faloppa, A. C. B., Calixto, L. A., et al. (2020). A new medium-throughput screening design approach for the development of hydroxymethylnitrofurazone (NFOH) nanostructured lipid carrier for treating leishmaniasis. Colloids and Surfaces B: Biointerfaces, 193, 1-8 art. 111097. doi:10.1016/j.colsurfb.2020.111097
NLM
Souza A de, Yukuyama MN, Barbosa EJ, Monteiro LM, Faloppa ACB, Calixto LA, Araujo GLB de, Fotaki N, Löbenberg R, Bou-Chacra NA. A new medium-throughput screening design approach for the development of hydroxymethylnitrofurazone (NFOH) nanostructured lipid carrier for treating leishmaniasis [Internet]. Colloids and Surfaces B: Biointerfaces. 2020 ; 193 1-8 art. 111097.[citado 2024 out. 16 ] Available from: https://doi.org/10.1016/j.colsurfb.2020.111097
Vancouver
Souza A de, Yukuyama MN, Barbosa EJ, Monteiro LM, Faloppa ACB, Calixto LA, Araujo GLB de, Fotaki N, Löbenberg R, Bou-Chacra NA. A new medium-throughput screening design approach for the development of hydroxymethylnitrofurazone (NFOH) nanostructured lipid carrier for treating leishmaniasis [Internet]. Colloids and Surfaces B: Biointerfaces. 2020 ; 193 1-8 art. 111097.[citado 2024 out. 16 ] Available from: https://doi.org/10.1016/j.colsurfb.2020.111097
Artigo de periodico
Cutting-edge advances in therapy for the posterior segment of the eye: solid lipid nanoparticles and nanostructured lipid carriers (2020)
Oliveira, Isabela Fernandes de; Barbosa, Eduardo José ; Peters, Maria Christina Camasmie ; Henostroza, Mirla Anali Bazan; Yukuyama, Megumi Nishitani; Santos Neto, Edson dos; Löbenberg, Raimar ; Bou-Chacra, Nadia Araci
Source: International Journal of Pharmaceutics. Unidade: FCF
Subjects: NANOPARTÍCULAS, LIPÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Isabela Fernandes de et al. Cutting-edge advances in therapy for the posterior segment of the eye: solid lipid nanoparticles and nanostructured lipid carriers. International Journal of Pharmaceutics, v. 589, p. 1-11 art. 119831, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2020.119831. Acesso em: 16 out. 2024.
APA
Oliveira, I. F. de, Barbosa, E. J., Peters, M. C. C., Henostroza, M. A. B., Yukuyama, M. N., Santos Neto, E. dos, et al. (2020). Cutting-edge advances in therapy for the posterior segment of the eye: solid lipid nanoparticles and nanostructured lipid carriers. International Journal of Pharmaceutics, 589, 1-11 art. 119831. doi:10.1016/j.ijpharm.2020.119831
NLM
Oliveira IF de, Barbosa EJ, Peters MCC, Henostroza MAB, Yukuyama MN, Santos Neto E dos, Löbenberg R, Bou-Chacra NA. Cutting-edge advances in therapy for the posterior segment of the eye: solid lipid nanoparticles and nanostructured lipid carriers [Internet]. International Journal of Pharmaceutics. 2020 ; 589 1-11 art. 119831.[citado 2024 out. 16 ] Available from: https://doi.org/10.1016/j.ijpharm.2020.119831
Vancouver
Oliveira IF de, Barbosa EJ, Peters MCC, Henostroza MAB, Yukuyama MN, Santos Neto E dos, Löbenberg R, Bou-Chacra NA. Cutting-edge advances in therapy for the posterior segment of the eye: solid lipid nanoparticles and nanostructured lipid carriers [Internet]. International Journal of Pharmaceutics. 2020 ; 589 1-11 art. 119831.[citado 2024 out. 16 ] Available from: https://doi.org/10.1016/j.ijpharm.2020.119831

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Non normalized affiliation